Dennis M. McGrath

CIK: 0001269340

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

DRIO

DarioHealth Corp.

Director

PAVM

PAVmed Inc.

Officer

LUCD

Lucid Diagnostics Inc.

Officer

CTOR

CITIUS ONCOLOGY, INC.

Director

CTXR

Citius Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

DRIO
DarioHealth Corp.
Sep 24, 2026
Award(A)
Direct
61K shares-
PAVM
PAVmed Inc.
Apr 2, 2026
Award(A)
Direct
180K shares-
LUCD
Lucid Diagnostics Inc.
Feb 20, 2026
Award(A)
Direct
470K shares-
PAVM
PAVmed Inc.
Sep 30, 2025
Award(A)
Direct
150K shares-
CTOR
CITIUS ONCOLOGY, INC.
Sep 19, 2025
Award(A)
Direct
300K shares-
DRIO
DarioHealth Corp.
Sep 11, 2025
Award(A)
Direct
20K shares-
LUCD
Lucid Diagnostics Inc.
Feb 20, 2025
Award(A)
Direct
300K shares-
CTOR
CITIUS ONCOLOGY, INC.
Dec 12, 2024
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
CTXR
Citius Pharmaceuticals, Inc.
Nov 7, 2024
Award(A)
Stock Option (Right to Purchase Common Stock)
Direct
125K shares-

		Type	Shares	Price		Ownership
Sep 24, 2026	DRIO DarioHealth Corp.	Award(A)	61,000	-	$0	Direct
Apr 2, 2026	PAVM PAVmed Inc.	Award(A)	180,000	-	$0	Direct
Feb 20, 2026	LUCD Lucid Diagnostics Inc.	Award(A)	470,000	-	$0	Direct
Sep 30, 2025	PAVM PAVmed Inc.	Award(A)	150,000	-	-	Direct
Sep 19, 2025	CTOR CITIUS ONCOLOGY, INC.	Award(A)	300,000	-	-	Direct
Sep 11, 2025	DRIO DarioHealth Corp.	Award(A)	20,000	-	-	Direct
Feb 20, 2025	LUCD Lucid Diagnostics Inc.	Award(A)	300,000	-	-	Direct
Dec 12, 2024	CTOR CITIUS ONCOLOGY, INC.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Nov 7, 2024	CTXR Citius Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Purchase Common Stock)	125,000	-	-	Direct

1-9 of 9 transactions

About MCGRATH DENNIS M

MCGRATH DENNIS M (SEC CIK 0001269340) files insider reports with the SEC as Director of DarioHealth Corp. (DRIO), President and CFO of PAVmed Inc. (PAVM) and Chief Financial Officer of Lucid Diagnostics Inc. (LUCD). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 11 ownership filings by MCGRATH DENNIS M, all Form 4s, filed between Nov 12, 2024 and Sep 28, 2026. Those filings report 9 transactions, from Nov 7, 2024 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MCGRATH DENNIS M's filings is in NEW YORK, NY.

Recent filings by MCGRATH DENNIS M

Sep 24, 2026: Grant or award of DRIO shares (Form 4, code A).
Apr 2, 2026: Grant or award of PAVM shares (Form 4, code A).
Feb 20, 2026: Grant or award of LUCD shares (Form 4, code A).
Sep 30, 2025: Grant or award of PAVM shares (Form 4, code A).
Sep 19, 2025: Grant or award of CTOR shares (Form 4, code A).

Other insiders filing for DarioHealth Corp. (DRIO)

PALUMBO JOHN R, Director
STERN ADAM K, Director
Shaked Yoav, Director
Franco-Yehuda Chen, Chief Financial Officer
Matheis Dennis, Director
Karah Hila, Director

How to read Form 4 transaction codes